FDA OKs First Cancer Drug by Genetic Type, Not Organ of Origin

This news article has expired. Below you will find a short description about the news article and comments that were left by CancerCompass users.

Keytruda is targeted to specific cancers with specific DNA that can arise in multiple sites



You must be logged in to post comments.

We care about your feedback. Let us know how we can improve your CancerCompass experience.